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Policy Forum
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Introduction
HIV is highly stigmatized throughout
sub-Saharan Africa [1,2]. In studies conducted among general population samples,
stigma has been shown to impede uptake
of HIV testing and increase sexual risktaking behavior [3,4]. Among HIV-infected persons, stigma has also been associated
with inhibited serostatus disclosure to
sexual partners and potential treatment
supporters, delays in HIV antiretroviral
therapy (ART) initiation, and ART nonadherence [5,6,7]. The stigma of HIV also
intensifies the poverty, stress, and insecurity endemic to many resource-limited
settings [8], resulting in worsened mental
health [9], itself an important determinant
of AIDS-related mortality [10]. Until we
can better understand how to effectively
intervene to reduce the stigma of HIV, it
will continue to adversely affect the wellbeing of HIV-infected persons and undermine both treatment and prevention
efforts throughout sub-Saharan Africa.
Given the pressing need for effective
intervention, in this Policy Forum article
we argue that poverty alleviation should
be conceptualized as a potentially powerful yet understudied tool for confronting
the stigma of HIV. Beginning with a
conceptual discussion of stigma, we draw
on qualitative and epidemiological studies
to focus our attention on the perceived
disability, economic incapacity, and death
associated with HIV as key determinants
of stigma in numerous sub-Saharan African countries. We then explain how
poverty alleviation may help reduce the
stigma of HIV. In doing so we borrow
from disparate lines of inquiry, including
HIV research and programmatic work in
sub-Saharan Africa; the medical literature

Summary Points

N
N
N
N
N

Poverty is an important driver of HIV stigma.
HIV-related morbidity undermines HIV-infected persons’ ability to maintain their
full economic contributions to family and community life.
Stigmatization and exclusion from local solidarity networks erode food and
livelihood security, which undermine adherence to HIV treatment, further
perpetuating this cycle.
HIV treatment can improve the economic, mental, and social health of HIVinfected persons, but it may not be sufficient to reduce the stigma of HIV.
Livelihood interventions can reduce the stigma of HIV by directly targeting
poverty.

on other stigmatized conditions, such as
epilepsy and schizophrenia; and literature
from other fields, including anthropology,
economics, psychology, and sociology.

The Stigma of HIV in SubSaharan Africa
In many cultural contexts, the stigma of
HIV is largely driven by concerns about its
symbolic meanings [11]. Gilmore and
Somerville [12] argue that stigma is best
understood as a social process which
involves the exercise of power, along the
fault lines of these symbolic meanings, by
one group over another. Consistent with
their argument, stigma has historically
been deployed in a manner that serves to
reproduce inequalities that existed even
prior to the HIV epidemic, thereby

displacing already-marginalized groups
even further downward in the status
hierarchy (Box 1). For example, during
the first decade of widespread awareness
about the epidemic in the US, HIV was
associated with marginalized groups perceived to be deviant or engaged in deviant
behavior, such as injection drug users and
men who have sex with men.
Although in some sub-Saharan African
countries the stigma of HIV may be partly
rooted in its association with perceived
deviance, others have argued that such an
account insufficiently explains persisting
negative attitudes toward HIV-infected
persons [13,14,15]. We hypothesize that
an overlooked—and under-targeted—driver of HIV stigma is its powerful association
with disability, economic incapacity, and
death. Our hypothesis is grounded in the
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Figure 1. Relationships between HIV, disability, and stigma. HIV infection has adverse
health and economic impacts, undermining HIV-infected persons’ abilities to maintain their full
economic contributions to family and community life and engage in reciprocal exchange.
Stigmatization and exclusion from local solidarity networks erodes their food and livelihood
security, which in turn undermine their adherence to ART. Non-adherence to ART perpetuates this
cycle by further compromising health and economic viability.
doi:10.1371/journal.pmed.1001557.g001

observation that, in settings of generalized
poverty where subsistence agriculture is the
norm and where social protection schemes
are limited, it is a critical aspect of human
sociality to be perceived as sufficiently fit to
engage in physical labor [16,17] and to be
perceived as actively contributing to networks of mutual aid [18]. Economic
incapacity resulting from HIV-associated

morbidity, and the specter of impending
premature mortality, call into question
HIV-infected persons’ abilities to support
their households via productive labor or to
engage in reciprocal exchange, thereby
singling them out for social exclusion
(Figure 1).
The mechanism we describe here has
been identified as a key culprit explaining

Box 1. The Stigma Process

N
N
N
N
N
N

Goffman [70] described stigma as an attribute that is ‘‘deeply discrediting’’ and
that, in the eyes of society, reduces someone ‘‘from a whole and usual person
to a tainted, discounted one’’ (p. 3).
Persons with and without the stigmatized attribute are separated into two
categories: ‘‘them’’ vs. ‘‘us’’ [71,72].
Internalized stigma results when stigmatized persons come to accept these
inhospitable attitudes as valid, thereby developing self-defacing beliefs and
perceptions about themselves [73].
Enacted stigma results when clandestine hostility and/or overt acts of
discrimination are directed towards persons specifically because they possess
the stigmatized attribute [71].
In such an environment, even stigmatized persons who are not directly
victimized may experience fear in anticipation of being targeted (felt stigma)
[74].
These processes are contingent on differentials in power [12,75].
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the corroded social status of HIV-infected
persons in different settings throughout
sub-Saharan Africa [19]. Table S1 provides examples of qualitative studies from
sub-Saharan Africa in which poverty and
inability to engage in reciprocal exchange
were cited as drivers of stigma. For
example, a young man from a community
sample in Zimbabwe portrayed HIVinfected persons as a drain on their
communities: ‘‘Right now those who are
infected are not treated as fellow human
beings. They are already declared dead,
and regarded as useless as a grave… They
mean that these people are no longer able
to do anything useful. They say they are
just waiting for the day of their death’’
[20] (p. 2275). These attitudes are embedded in local descriptions of HIV-infected
persons who have been labeled ‘‘corpses
that live’’ [13] (p. 848). Table S2 lists other
dysphemisms that have been applied to
HIV-infected persons in countries
throughout sub-Saharan Africa.
The conceptual discussion above describes both symbolic and instrumental
drivers of stigma [11]. On the one hand,
its symbolic component is derived from
what HIV symbolizes in specific cultural
contexts: disability, economic incapacity,
and death. On the other hand, the
exclusion of economically inadequate persons from participation in local solidarity
networks can be viewed as instrumental,
i.e., serving a utilitarian function. This
view of stigma emphasizes the instrumental, rather than the symbolic, value of
stigma to groups who are in a position to
engage in the type of exercise of power
described above. The instrumental basis
for stigmatization has been elaborated
from an evolutionary perspective by social
psychologists who treat stigma as a
behavioral adaptation designed to solve
one of the central problems of human
sociality: the need for long-term, cooperative, reciprocal exchange [21,22]. Persons targeted for stigmatization are simply
those who are perceived to violate the
norm of reciprocity.
The stigma of HIV can also be
understood using concepts borrowed from
social capital theory. Persons living in
settings of generalized poverty rely heavily
on social capital (specifically, bonding and
bridging social capital [23]) to access
material resources needed for survival.
These themes are prominently described
in numerous qualitative studies from subSaharan Africa [24,25,26,27,28]. The
motivating forces behind social capital
are not always altruistic, however, as
Portes and Sensenbrenner [29] argued.
When social capital is rooted in instru-
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mental rather than altruistic concerns,
persons who do not fulfill reciprocity
expectations can be excluded. Accordingly, in some communities, fear of the
‘‘social death’’ and exclusion resulting
from an HIV diagnosis is more intense
than the fear of the disease itself [30].
To date, a number of different approaches to stigma reduction have been
attempted. These have largely consisted of
educational interventions, aimed at the
general population to correct overblown
fears about casual transmission risks, or
contact interventions in which study
participants experience scripted interactions with HIV-infected persons in order
to increase tolerance and acceptance [31].
Under the framework described above,
these approaches can be thought of as
addressing either symbolic or instrumental
aspects of HIV stigma. Persons who are
exposed to an educational intervention
(that demonstrates how the risks of casual
transmission are much lower than they
previously thought) might be expected to
revise their instrumental concerns about
HIV. Similarly, persons who are exposed
to HIV-infected persons through a contact
intervention might be inclined to revise
their symbolically grounded views about
the humanity of HIV-infected persons (a
process termed ‘‘recategorization’’ [32]).
These approaches, however, do not necessarily consider the underlying functional
aspects of HIV stigma.

ART Scale-Up as a Necessary
but Not Sufficient Stigma
Reduction Strategy
If an important driver of HIV stigma is
its powerful association with disability,
economic incapacity, and death, then
ART might receive an alternative reading
as an anti-stigma intervention. Although
ART is deployed at the level of the
individual, it should also be regarded as a
structural intervention aimed at altering
the context in which HIV-infected persons
interact with their HIV-uninfected peers
[33]. We conceptualize HIV treatment as
increasing the perceived social value of
HIV-infected persons, by detaching the
perceived inevitability of death from HIV
infection and by directly addressing societal assessments about one’s ability to
adhere to norms of reciprocity. Consistent
with this hypothesis, epidemiologic and
econometric studies have demonstrated
that the availability of and perceived
access to ART have altered general
population expectancies about longevity
in Malawi [34,35] and diminished negative attitudes towards HIV-infected perPLOS Medicine | www.plosmedicine.org

sons in Botswana [2]. In fact, an early
argument advanced in support of ART
scale-up was that doing so would reduce
stigma and enhance prevention efforts
[36].
For HIV-infected persons, the past
decade of ART expansions has vindicated
these claims. Program implementers at the
non-governmental organization Partners
in Health, for example, reported that after
the introduction of ART in Haiti, they
observed greater demand for HIV testing
and counseling, and their patients reported fewer HIV-related discriminatory
events and increased social integration
[36,37]. As shown in Table S1, in
qualitative studies conducted in countries
throughout sub-Saharan Africa, HIV-infected persons initiating ART have similarly described a constellation of benefits,
including improved economic productivity, greater self-efficacy, and reduced internalized stigma [38]. These findings have
been confirmed in larger-scale epidemiological studies as well [9,39,40,41,42,
43,44].
Yet, while ART has undeniably improved the economic, mental, and social
health of HIV-infected persons, two factors may hinder its ability to level
stigmatizing beliefs in the general population. First, accurate knowledge about
ART efficacy may not evenly follow the
contours of treatment expansion. Over the
past decade, with substantial investments
in educational HIV-related messages promoted through radio, television, and/or
print media, overall levels of accurate
HIV-specific knowledge have improved
slightly but remain low in general population surveys conducted throughout subSaharan Africa [45]. Similarly, local
beliefs about ART availability or ART
efficacy may also lag, thereby perpetuating
the assumed association between HIV and
disability, economic incapacity, and death.
This could potentially explain why uptake
of HIV testing throughout sub-Saharan
Africa, while increasing over time, has
remained persistently low despite largescale expansions in access to ART [46].
Refusal of treatment despite eligibility has
also been described [47].
Second, ART alone may not be sufficient to decrease the stigma of HIV.
Despite expansions in access to ART at
no charge, many patients present for
treatment initiation late in the disease stage.
As a result, even when they experience
dramatic recovery of physical function,
they may return to work at a lower intensity
compared to their pre-disease state
[17,18,48,49]. In addition, even HIVinfected persons who are able to resume
3

working at full capacity have nonetheless
voiced difficulties in rebounding to the
same overall level of economic well-being.
While trying to cope with HIV-associated
morbidity before treatment initiation, they
may have had to adopt coping strategies
such as selling off productive assets or
shifting from high-return to low-return
activities, while ultimately undermining
their own financial viability in the long
term. These themes are prominent in
qualitative studies [16,17,19,27,49] and
have been confirmed in larger-scale epidemiological studies [50].

‘‘ART-Plus’’: Harnessing Poverty
Alleviation to Reduce the
Stigma of HIV
Considering the important limitations
in our current portfolio of anti-stigma
interventions [31], we believe poverty
alleviation—and, specifically, livelihood
interventions—should also be considered
in conjunction with ART to help further
reduce the stigma of HIV. We recognize
that the idea of ‘‘ART-plus’’ does not, at
present, have widespread adherents. For
example, a recently published Cochrane
Collaboration protocol for a planned
systematic review of interventions to
reduce HIV stigma lists an exhaustive
catalogue of educational anti-stigma
interventions, including ‘‘lectures, group
discussions, individual education, radio,
television, print (newspapers, magazines,
booklets, leaflets, posters, pamphlets),
films, documentaries, billboards, folk media (such as street dramas), or a combination of these’’ [51] (p. 4) but does not
provide any indication that livelihood
interventions will be examined.
The hypotheses we describe in this
article are consistent with an argument
advanced by Castro and Farmer [37], who
prominently called attention to the ways in
which the stigma of HIV is mainly
determined by large-scale social forces
such as poverty and racial and gender
inequality. Drawing on their programmatic and research experience with HIVinfected persons in Haiti, they write,
‘‘poverty, already representing an almost
universal stigma, will be the primary
reason that poor people living with HIV
suffer from greater AIDS-related stigma’’
(p. 55). Conceptually, this line of argument suggests that HIV-related stigmatization may at least be partially conditioned on poverty, extending the cognitive
and psychological models described above
to emphasize how power relations and
economic and other structural factors
influence community responses to HIV.
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Figure 2. Transforming HIV-stigmatizing beliefs through ART-plus. ART manages the
disability incurred through HIV infection, undermining the view of HIV-infected persons as
economically inadequate members of the community and permitting them to re-engage in
productive activity. Livelihood interventions, such as combined financial literacy and
microenterprise management programs, may additionally create new modes of engaging in
productive activity, such as new trades or new enterprise development. These financial
contributions are welcomed within local solidarity networks, and the norm of reciprocity is
upheld.
doi:10.1371/journal.pmed.1001557.g002

Qualitative studies from Brazil [52], Zambia [53], and Zimbabwe [54] have generated similar conclusions.
Non-governmental organizations have
already moved forward with programs to
address these issues [41,55,56,57,58]. Indeed, the summary term we have adopted
here, ‘‘ART-plus,’’ is borrowed from a
Peruvian non-governmental organization’s
pilot program that employed a comprehensive HIV treatment strategy with both
ART and socioeconomic support [55]. Yet
although the multiple lines of inquiry
described in this article provide sufficient
groundwork to justify the implementation of experimental or quasi-experimental
studies, to date the available evidence in
this area has been exclusively observational.
In qualitative studies of HIV-infected
persons participating in integrated livelihood intervention programs in different
sub-Saharan African settings, study participants reported less stigma, increased social
integration, and improved status in the
community (Table S1). These changes were
explicitly linked to their improved economic standing, as one program staff member
observed: ‘‘Some participants…have gained
[a] reputation within their communities…
Because of the cow, because of the income
they are getting, they have been taking
on positions of responsibility in their
PLOS Medicine | www.plosmedicine.org

communities, in churches, in schools, on
boards…they are now getting less stigmatized in a sense… [the community] can see
them managing their own issues, managing
themselves, surviving…’’ [58] (p.e26117).
In other words, by availing themselves of
economic opportunities brought about
through these interventions, HIV-infected
persons were able to construct ‘‘positive
identities’’ for themselves in much the same
fashion as when they were first restored to
health after initiating ART [54] (p. 1008).
Additional evidence comes from a longitudinal study with matched controls, in
which Muñoz and colleagues [59] studied
the psychosocial impacts of a comprehensive
social support intervention among 120 HIVinfected persons receiving ART in Peru. At
24-month follow-up, participants in the
intervention group reported less stigma and
perceived greater social support. Because
only ten of these actually received individually tailored microfinance assistance, there
was limited ability to draw inferences about
the incremental stigma-reducing effects of
the microfinance assistance component of
the intervention. However, studies of similar
types of interventions based on participant
samples unselected for HIV seropositivity
have shown statistically significant impacts
on mental health [60,61] and social integration [62], thereby lending further plausibility
4

to the effects shown by Muñoz and
colleagues [59].
A simplified diagram summarizing our
hypotheses about how ART-plus revises
HIV-stigmatizing beliefs is shown in
Figure 2. In our account, ART-plus
addresses internalized stigma, by enhancing the HIV-infected person’s self-efficacy
and self-esteem. This aspect of our framework is most closely related to the conceptual model and empirical study by Rosenfield [63], who identified links between
economic rehabilitation, self-efficacy, social
status, and subjective quality of life among
functionally impaired persons with mental
illness in the US. Further, if the objective is
‘‘recategorization’’ (as described above in
the context of contact interventions), ARTplus also offers a different type of recategorization to address enacted stigma, by
encouraging a view of HIV-infected persons not as a net drain on their communities but rather as productive members of
society who are ‘‘managing their own
issues’’ [58] (p.e26117).

Limitations of the ART-Plus
Approach
We recognize several potential pitfalls
with this proposed ART-plus approach to
stigma reduction. First, while we believe that
the perceived association between HIV and
disability, economic incapacity, and death is
a primary driver of stigma, we also recognize
that stigma is complex and may be driven by
many other factors depending on the
cultural context. Despite dramatic expansions in access to ART in urban South
Africa, for example, a longitudinal study by
MaughanBrown [64] showed continued increases in
symbolic stigma centered around the association of HIV with promiscuity. Similarly, a
common prominent theme in several qualitative studies from Tanzania was a negative
perception of HIV-infected persons that
persisted specifically because of ART’s effects
on prolonging life [65,66]. Study participants voiced concerns that ART changed
HIV-infected persons from diseased but
visibly ill and incapable of sexual risk-taking
behavior, to diseased but healthy-appearing
potential vectors of sexual transmission. In
settings where such symbolism is a secondary but nonetheless substantial driver of
stigma, even if a combined ART-plus
intervention could undo the association
between HIV, disability, and economic
incapacity, it would still ‘‘leave the spectre
of illicit sex untouched’’ [67] (p. 643).
A second issue that poses a dilemma for
the implementation of our proposed
strategy, without undermining the strategy

November 2013 | Volume 10 | Issue 11 | e1001557

itself, is that precisely targeting this type of
intervention may be politically difficult.
Making economic resources available specifically to HIV-infected persons in the
context of widespread poverty may generate resentment not unlike the antipathy
directed towards welfare recipients in the
US beginning in the 1970s and continuing
to the present day. For example, participants in a qualitative study from South
Africa intimated that welfare fraud was
widespread among HIV-infected persons
receiving disability grants [68]. Because of
these reasons, there is a consensus that
broad-based targeting schemes (e.g., based
on poverty and multiple vulnerability
criteria) for cash transfer interventions
should be used rather than procedures
focused on HIV-affected status or orphanhood alone [69]. However, interventions
that focus on livelihoods, such as animal
husbandry training or microfinance assistance for small enterprises, may be perceived in the community to be more

sustainable than interventions that provide
direct food or cash transfers and therefore
engender less resentment [58].

target both the stigmatized (through
livelihood interventions) as well as the
stigmatizers (through educational or contact interventions).

Conclusion
Taken together, these related strands of
inquiry build a strong case for considering livelihood interventions as a compelling stigma reduction strategy with the
potential to improve the well-being of
HIV-infected persons throughout subSaharan Africa. Although our framework
has not been rigorously tested in an
experimental context, we believe the
corroborating evidence from anthropology, economics, psychology, and sociology
is strongly suggestive. It would be imprudent for us to suggest that prevailing
approaches to stigma should be abandoned despite their uneven effectiveness
to date. Future studies may find that the
most effective approaches to stigma
reduction adopt synergistic strategies that
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